A technology considered
within the whole system.
For hospital executives, imaging-center leaders, breast-imaging program directors, administrators, and operations stakeholders, MammoGRIP® belongs in a disciplined conversation about positioning, patient experience, workflow, and evidence.
Positioning is a clinical step with operational context
MammoGRIP® is designed to support the technologist at the point of image acquisition. For an institution, that means evaluating a focused technology within existing mammography procedures rather than treating it as a replacement for equipment, software, or professional expertise.
Evaluation may include the center’s positioning workflow, patient communication, staff experience, supply practices, clinical governance, and the way preliminary evidence is reviewed. Local protocols and institutional judgment remain essential.
One workflow, several responsibilities
Hospital executives
Assess strategic fit, governance, patient-centered priorities, and responsible implementation.
Imaging-center leaders
Examine workflow integration, staff adoption, quality processes, and evaluation design.
Breast-imaging programs
Consider positioning practice, image-acquisition context, and evidence review.
Purchasing & operations
Review product use, supply planning, training expectations, and local requirements.
A conservative way to frame cost
per examination
The approved project framing is deliberately limited: MammoGRIP® may approach cost-neutrality under favorable conditions.
For local evaluation, approved value mechanisms may include reduced repositioning, workflow efficiency, equipment utilization, downstream detection value, patient adherence, and technologist experience. These are evaluation considerations—not promised outcomes.
Any institutional assessment should be based on the center’s actual utilization, workflow, supply policies, and evaluation criteria. This page does not provide ROI, revenue, throughput, labor-saving, equipment-life, or guaranteed-savings calculations.
Evidence should guide the conversation
Institutional review should distinguish ongoing product investigations, patient-experience findings, and published literature. Englewood Health remains an ongoing single-center pilot investigation, and preliminary results should not be treated as completed or definitive evidence.
Explore the study details and educational context on the Clinical Evidence page.